SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
Go back to SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)| (NASDAQ: AQST) | Delayed: 4.12 +0.18 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.94 | 52 Week High | $ | |||
| Open | $3.89 | 52 Week Low | $ | |||
| Day High | $4.16 | P/E | N/A | |||
| Day Low | $3.81 | EPS | $ | |||
| Volume | 2,356,257 | |||||
| SCYNEXIS (NASDAQ: SCYX) | Delayed: 4.27 -0.21 (4.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.48 | 52 Week High | $7.29 | |||
| Open | $4.44 | 52 Week Low | $1.74 | |||
| Day High | $4.67 | P/E | N/A | |||
| Day Low | $4.23 | EPS | $0.00 | |||
| Volume | 22,838 | |||||
